FDA approves Lynparza for HRR gene-mutated castration-resistant prostate cancer May 20, 2020 No Comments
Opdivo + Yervoy approved in U.S. for first-line metastatic NSCLC with PD-L1 expression >= 1% May 18, 2020 No Comments
RSS